Evidence map›Paper›PMID 38663881›Full record

ArticleRMD open2024

Optimising gout treatment: insights from a nurse-led cohort study.

Claus Rasmussen, Jesper Walther Larsen, Heidi Mächler Christensen, Monica Bak Larsen, Anna Marie Thomsen, Tinna Leishmann, Jette Kragh, Gunnar Lauge Nielsen

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Gout therapy updated.Therapeutic advances in musculoskeletal disease · 2025
    Review
  6. Article
  7. Gout: An Overlooked Disease in Patients With Diabetes? A Danish Prospective Cohort Study With 2 Years of Follow-Up.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Claus RasmussenDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark clara@rn.dk.ORCID 0000-0001-8543-8447
Jesper Walther LarsenDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0009-0000-3794-0942
Heidi Mächler ChristensenDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0009-0001-7170-2646
Monica Bak LarsenDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0000-0001-5468-4944
Anna Marie ThomsenDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0009-0007-0751-6041
Tinna LeishmannDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0009-0001-7020-3351
Jette KraghDepartment of Rheumatology, North Denmark Regional Hospital, Hjorring, Denmark.ORCID 0000-0002-6956-9698
Gunnar Lauge NielsenClinical Medicine, Aalborg Universitet, Aalborg, Denmark.ORCID 0000-0002-9618-9922
North Denmark Region · DKAalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCurrently, gout management, particularly urate-lowering therapy (ULT), is often suboptimal. Nurses successfully manage various diseases including gout. As gout prevalence is rising, and rheumatologists and general practitioners face shortages, a new approach is imperative. This real-life prospective cohort study evaluated the effectiveness of nurse-led care employing a treat-to-target strategy for gout management over a 2-year period.

methodsAll consecutively confirmed gout patients were included. The nurse-led clinic provided a structured treatment plan with consultations, patient leaflets, telephone contacts and laboratory monitoring. After a year of nurse-led care, patients transitioned to continued care in general practice. Follow-up data were complete through registries. The primary outcome was achieving target p-urate levels (<0.36 mmol/L) at 2 years after diagnosis. Secondary outcomes included treatment continuation and achievement of target p-urate levels in specific subgroups. The results were compared with patients diagnosed in the same clinic but followed up in 'usual care'.

resultsIn the nurse-led group (n=114), 83% achieved target p-urate levels and ULT was continued by 98%. This trend persisted across various patient subgroups. Only 44% of patients in usual care achieved target p-urate and with insufficient doses of allopurinol . Nurse-led care involved an average of two visits and three telephone contacts over 336 days. The 2-year mortality rate was 15%.

conclusionsNurse-led gout care, employing a targeted approach, was associated with a very high uptake of and adherence to ULT. The encouraging results were not achieved in usual care although a direct comparison might be influenced by selection bias.

Indexed as

GoutGout SuppressantsUric AcidAgedAllopurinolDisease ManagementFemaleHumansMaleMiddle AgedPractice Patterns, Nurses'Prospective StudiesTreatment OutcomeAllopurinolGout SuppressantsUric AcidCrystal arthropathiesGoutHealth services researchNursing

Identifiers

PMID38663881
PMCPMC11043733
OpenAlexW4395479601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.